Search

Search Results

• 

  SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials

  Tariq Jamal Siddiqi, Javed Butler, Andrew J.S. Coats, Subodh Verma, Tim Friede, Gerasimos Filippatos, Stefan D. Anker

  2023-11-23

  Published: November 23, 2023

  685

  pdf: 121

  Supplementary Material: 19

  HTML: 17
• 

  Iron deficiency in heart failure with preserved ejection fraction: rationale and design of the FAIR-HFpEF trial

  Stephan von Haehling, Wolfram Doehner, Ruben Evertz, Tania Garfias-Veitl, Monika Diek, Mahir Karakas, Ralf Birkemeyer, Gerasimos Fillippatos, Piotr Ponikowski, Michael Böhm, Tim Friede, Stefan D. Anker

  2023-12-27

  Published: December 27, 2023

  1737

  pdf: 279

  HTML: 9
• 

  Evolving targets for heart failure: the journey so far

  Giuseppe M.C. Rosano, Jerneja Farkas

  2023-11-28

  Published: November 28, 2023

  1473

  pdf: 117

  HTML: 3
• 

  Clinical trial design, endpoints and regulatory considerations in heart failure

  Giuseppe M.C. Rosano

  2024-03-28

  Published: March 28, 2024

  5092

  PDF: 218

  HTML: 68
• 

  Intervention options: depression and cardiovascular disease during COVID-19

  Eirini Flouda, Athena Stefanatou, Tinia Apergi

  2023-11-28

  Published: November 28, 2023

  1319

  pdf: 97

  HTML: 2
• 

  The scientific targets: the myocardium, the vasculature and the body’s response to heart failure

  Rafael Vidal-Pérez, Ewa A. Jankowska

  2024-03-28

  Published: March 28, 2024

  2168

  PDF: 71

  HTML: 14